Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics (DMAC) Cash from Financing Activities (2018 - 2019)

Historic Cash from Financing Activities for DiaMedica Therapeutics (DMAC) over the last 2 years, with Q4 2019 value amounting to -$1000.0.

  • DiaMedica Therapeutics' Cash from Financing Activities fell 10000.68% to -$1000.0 in Q4 2019 from the same period last year, while for Dec 2019 it was $70000.0, marking a year-over-year decrease of 9967.01%. This contributed to the annual value of $12.0 million for FY2024, which is 6744.48% down from last year.
  • Latest data reveals that DiaMedica Therapeutics reported Cash from Financing Activities of -$1000.0 as of Q4 2019, which was down 10000.68% from -$1000.0 recorded in Q3 2019.
  • Over the past 5 years, DiaMedica Therapeutics' Cash from Financing Activities peaked at $14.8 million during Q4 2018, and registered a low of -$2000.0 during Q1 2019.